This inventor holds 1 USPTO granted patent. Top assignee: Domantis Limited. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Roland Beckmann: Innovator in Cancer Therapy
Introduction
Roland Beckmann is a notable inventor based in Geneva, Switzerland. He has made significant contributions to the field of cancer therapy through his innovative research and patents. His work focuses on developing ligands that target specific growth factors, which are crucial in cancer treatment.
Latest Patents
Beckmann holds a patent for "Ligands that have binding specificity for VEGF and/or EGFR and methods of use therefor." This patent discloses ligands that exhibit binding specificity for vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR). The methods of using these ligands, particularly in cancer therapy, are also described in detail.
Career Highlights
Beckmann is associated with Domantis Limited, a company that specializes in biopharmaceuticals. His work at Domantis has been instrumental in advancing therapeutic options for cancer patients. With a focus on innovative solutions, he continues to contribute to the scientific community.
Collaborations
Some of his notable coworkers include Olga Ignatovich and Steve Holmes. Their collaborative efforts have further enhanced the research and development of effective cancer therapies.
Conclusion
Roland Beckmann's contributions to cancer therapy through his innovative patents and collaborations highlight his importance in the field of medical research. His work continues to pave the way for advancements in treatment options for cancer patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile